Search
for
Sort by
Research 241–270 of 1000+
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Mammalian Fetal Organ Regeneration
- Immune cell regulation of the hair cycle
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Hidradenitis Suppurativa
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- The concealed side of caspases: beyond a killer of cells
- Physiology and Medical Treatments for Alopecia
- Dermatologic Care of the Transplant Patient
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Pharmacological Treatment of Alopecia
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Alopecia areata
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Pharmacotherapy of alopecia areata
- Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Interleukin-15 is a hair follicle immune privilege guardian
- JAK Inhibitors for Treatment of Alopecia Areata